Review
Open access
Aug 2026
Beyond Canonical Neoantigens: Emerging Technologies for Identification of Noncanonical Antigens and Implications for Personalized Cancer Vaccines
The diverse sources and identification technologies of aberrant cancer-associated proteins beyond genetic mutations are described and highlighted to highlight their clinical relevance in next-generation PCVs.
Yi-Lin Yang, Thomas Kane, Abdurrahman Abdelzaher et al.
· Cancers · 0 citations